None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged between 19 and 75 years who are scheduled for implant placement in the maxillary posterior edentulous area at Seoul National University Dental Hospital and have provided written consent. Patients with a residual alveolar bone width of at least 7 mm and a vertical distance of 3-5 mm from the residual alveolar bone to the maxillary sinus. Individuals with at least 20 remaining teeth, including any artificial teeth in the oral cavity. Patients with a plaque index and bleeding on probing index of less than 20%. Patients who have received a detailed explanation of the study, understood it, and have voluntarily decided to participate and provided consent.
Exclusion criteria
Exclusion criteria: Individuals with systemic diseases that could affect treatment outcomes. Patients who have experienced unstable angina, myocardial infarction, or transient ischemic attack within the last six months. Individuals who have undergone coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG). Patients who have experienced severe cerebrovascular accidents (stroke, cerebral infarction, cerebral hemorrhage, etc.) within the last six months. Those with clinically significant renal or liver function abnormalities. Patients with uncontrolled diabetes. Individuals deemed unsuitable for participation in this study by the principal investigator or attending staff.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implant stability | — |
Secondary
| Measure | Time frame |
|---|---|
| Implant survival rate | — |
Countries
Korea, Republic of
Contacts
Seoul National University Dental Hospital